Pro ‐protein subtilisin kexin‐9 (PCSK9) inhibition in practice: lipid clinic experience in 2 contrasting UK centres

ConclusionsThis study suggests that PCSK‐9 inhibitors are effective but that prescriptions should not be changed to long‐term delivery until patients have been reviewed and shown to be adherent.

Source: International Journal of Clinical Practice - October 1, 2017 Category: Internal Medicine Authors: Monika Kohli, Kinjal Patel, Zofia MacMahon, Radha Ramachandran, Martin A. Crook, Timothy M. Reynolds, Anthony S. Wierzbicki Tags: ORIGINAL PAPER Source Type: research